XBIOTECH INC. Investment Income, Net
XBIOTECH INC. (XBIT) reported Investment Income, Net of $885.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2026-08-13
- XBIOTECH INC. investment income, net for the quarter ending 2026-06-30 was $885.00K, a 42.16% decline year-over-year.
- XBIOTECH INC. investment income, net for the quarter ending 2026-03-31 was $914.00K, a 39.23% decline year-over-year.
- XBIOTECH INC. investment income, net for the quarter ending 2025-12-31 was $1.22M, a 41.84% decline year-over-year.
- XBIOTECH INC. investment income, net for the quarter ending 2025-09-30 was $1.43M, a 39.76% decline year-over-year.
- XBIOTECH INC. investment income, net for fiscal 2025 was $5.68M, a 42.12% decline from fiscal 2024.
- XBIOTECH INC. investment income, net for fiscal 2024 was $9.81M, a 5.84% decline from fiscal 2023.
- XBIOTECH INC. investment income, net for fiscal 2023 was $10.42M, a 172.59% increase from fiscal 2022.
- XBIOTECH INC. investment income, net for fiscal 2022 was $3.82M, a 718.63% increase from fiscal 2021.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $885.00K 10-Q · filed 2026-08-13 | $1.80M 10-Q · filed 2026-08-13 | $3.02M derived: sum of 3 quarters · filed 2026-08-13 | $4.45M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $914.00K 10-Q · filed 2026-05-14 | $2.13M derived: sum of 2 quarters · filed 2026-05-14 | $3.56M derived: sum of 3 quarters · filed 2026-05-14 | $5.09M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $2.65M derived: sum of 2 quarters · filed 2026-03-13 | $4.18M derived: sum of 3 quarters · filed 2026-08-13 | $5.68M 10-K · filed 2026-03-13 |
| 2025-09-30 | $1.43M 10-Q · filed 2025-11-12 | $2.96M derived: sum of 2 quarters · filed 2026-08-13 | $4.46M 10-Q · filed 2025-11-12 | $6.56M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $1.53M 10-Q · filed 2026-08-13 | $3.03M 10-Q · filed 2026-08-13 | $5.13M derived: sum of 3 quarters · filed 2026-08-13 | $7.50M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.50M 10-Q · filed 2026-05-14 | $3.60M derived: sum of 2 quarters · filed 2026-05-14 | $5.97M derived: sum of 3 quarters · filed 2026-05-14 | $8.66M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $4.46M derived: sum of 2 quarters · filed 2026-03-13 | $7.15M derived: sum of 3 quarters · filed 2026-03-13 | $9.81M 10-K · filed 2026-03-13 |
| 2024-09-30 | $2.37M 10-Q · filed 2025-11-12 | $5.06M derived: sum of 2 quarters · filed 2025-11-12 | $7.72M 10-Q · filed 2025-11-12 | $10.32M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $2.69M 10-Q · filed 2025-08-13 | $5.35M 10-Q · filed 2025-08-13 | $7.95M derived: sum of 3 quarters · filed 2025-08-13 | $10.48M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $2.66M 10-Q · filed 2025-05-14 | $5.26M derived: sum of 2 quarters · filed 2025-05-14 | $7.79M derived: sum of 3 quarters · filed 2025-05-14 | $10.30M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $5.13M derived: sum of 2 quarters · filed 2025-03-18 | $7.64M derived: sum of 3 quarters · filed 2025-03-18 | $10.42M 10-K · filed 2025-03-18 |
| 2023-09-30 | $2.53M 10-Q · filed 2024-11-13 | $5.04M derived: sum of 2 quarters · filed 2024-11-13 | $7.82M 10-Q · filed 2024-11-13 | $10.29M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $2.51M 10-Q · filed 2024-08-12 | $5.29M 10-Q · filed 2024-08-12 | $7.76M derived: sum of 3 quarters · filed 2024-08-12 | $8.77M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $2.78M 10-Q · filed 2024-05-10 | $5.25M derived: sum of 2 quarters · filed 2024-05-10 | $6.26M derived: sum of 3 quarters · filed 2024-05-10 | $6.50M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $3.48M derived: sum of 2 quarters · filed 2024-03-15 | $3.72M derived: sum of 3 quarters · filed 2024-03-15 | $3.82M 10-K · filed 2024-03-15 |
| 2022-09-30 | $1.01M 10-Q · filed 2023-11-09 | $1.25M derived: sum of 2 quarters · filed 2023-11-09 | $1.35M 10-Q · filed 2023-11-09 | $1.46M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $241.00K 10-Q · filed 2023-08-11 | $343.00K 10-Q · filed 2023-08-11 | $452.00K derived: sum of 3 quarters · filed 2023-08-11 | $577.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $101.00K 10-Q · filed 2023-05-10 | $211.00K derived: sum of 2 quarters · filed 2023-05-10 | $336.00K derived: sum of 3 quarters · filed 2023-05-10 | $459.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $235.00K derived: sum of 2 quarters · filed 2023-03-15 | $358.00K derived: sum of 3 quarters · filed 2023-03-15 | $467.00K 10-K · filed 2023-03-15 |
| 2021-09-30 | $125.00K 10-Q · filed 2022-11-09 | $248.00K derived: sum of 2 quarters · filed 2022-11-09 | $357.00K 10-Q · filed 2022-11-09 | $485.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $123.00K 10-Q · filed 2022-08-10 | $232.00K 10-Q · filed 2022-08-10 | $360.00K derived: sum of 3 quarters · filed 2022-08-10 | $484.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $109.00K 10-Q · filed 2022-05-10 | $237.00K derived: sum of 2 quarters · filed 2022-05-10 | $361.00K derived: sum of 3 quarters · filed 2022-05-10 | $667.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $252.00K derived: sum of 2 quarters · filed 2022-03-15 | $558.00K derived: sum of 3 quarters · filed 2022-03-15 | $2.46M 10-K · filed 2022-03-15 |
| 2020-09-30 | $124.00K 10-Q · filed 2021-11-09 | $430.00K derived: sum of 2 quarters · filed 2021-11-09 | $2.33M 10-Q · filed 2021-11-09 | $2.51M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $306.00K 10-Q · filed 2021-08-09 | $2.20M 10-Q · filed 2021-08-09 | $2.39M derived: sum of 3 quarters · filed 2022-03-15 | $2.64M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $1.90M 10-Q · filed 2021-05-10 | $2.08M derived: sum of 2 quarters · filed 2022-03-15 | $2.33M derived: sum of 3 quarters · filed 2022-03-15 | $2.38M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $185.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $435.00K derived: sum of 2 quarters · filed 2022-03-15 | $486.00K derived: sum of 3 quarters · filed 2022-03-15 | $564.00K 10-K · filed 2022-03-15 |
| 2019-09-30 | $250.00K 10-Q · filed 2020-11-09 | $301.00K derived: sum of 2 quarters · filed 2020-11-09 | $379.00K 10-Q · filed 2020-11-09 | $509.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | $51.00K 10-Q · filed 2020-08-10 | $129.00K 10-Q · filed 2020-08-10 | $259.00K derived: sum of 3 quarters · filed 2021-03-16 | $359.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-03-31 | $78.00K 10-Q · filed 2020-05-11 | $208.00K derived: sum of 2 quarters · filed 2021-03-16 | $308.00K derived: sum of 3 quarters · filed 2021-03-16 | $415.00K derived: sum of 4 quarters · filed 2021-03-16 |
| 2018-12-31 | $130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $230.00K derived: sum of 2 quarters · filed 2021-03-16 | $337.00K derived: sum of 3 quarters · filed 2021-03-16 | $400.00K 10-K · filed 2021-03-16 |
| 2018-09-30 | $100.00K 10-Q · filed 2019-11-12 | $207.00K derived: sum of 2 quarters · filed 2019-11-12 | $270.00K 10-Q · filed 2019-11-12 | $338.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | $107.00K 10-Q · filed 2019-08-09 | $170.00K 10-Q · filed 2019-08-09 | $238.00K derived: sum of 3 quarters · filed 2020-03-16 | $361.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | $64.00K 10-Q · filed 2019-05-09 | $131.00K derived: sum of 2 quarters · filed 2020-03-16 | $254.00K derived: sum of 3 quarters · filed 2020-03-16 | $368.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $190.00K derived: sum of 2 quarters · filed 2020-03-16 | $304.00K derived: sum of 3 quarters · filed 2020-03-16 | $354.00K 10-K · filed 2020-03-16 |
| 2017-09-30 | $123.00K 10-Q · filed 2018-10-31 | $237.00K derived: sum of 2 quarters · filed 2018-10-31 | $287.00K 10-Q · filed 2018-10-31 | |
| 2017-06-30 | $114.00K 10-Q · filed 2018-08-09 | $164.00K 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | $49.00K 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $49.00K 10-K/A · filed 2019-03-15 | |||
| 2014-12-31 | $1.00K 10-K · filed 2017-03-16 | |||
| 2013-12-31 | $1.00K 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |